Results 31 to 40 of about 428 (162)

Perforating collagenosis. [PDF]

Skin Health Dis
We show a case of a 69‐year‐old man with perforating collagenosis, which is a rare dermatosis commonly associated with diabetes mellitus. Papules and plaques with keratotic plugs are distinctive clinical characteristic of perforating collagenosis. Representative clinical images in our article can enhance the understanding of key concepts of perforating
Oya K, Saito A.
europepmc   +2 more sources

A double-arm, randomized, and controlled trial to compare the efficacy and safety of bepotastine with levocetirizine in patients of chronic spontaneous urticaria

National Journal of Physiology, Pharmacy and Pharmacology, 2022
Background: Second generation antihistamines are first line therapy for chronic spontaneous urticaria (CSU). Sedation has been always a concern as a side effect of antihistamine for both patients and treating dermatologist.
Ashish Kumar Rai, Shital Poojary, Lily Dubey, Pawan Gupta   +3 more
doaj   +1 more source

Comparative evaluation of efficacy and safety of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.1% ophthalmic solution in patients with vernal keratoconjunctivitis [PDF]

, 2021
Background: Vernal keratoconjunctivitis (VKC) is a chronic, seasonally exacerbated, allergic ocular inflammation. It affect children and young adults and has male predominance.
Gupta, Priya, Baishnab, Seema, Rewri, Parveen   +2 more
core   +1 more source

A prospective, randomized, open-label, active-controlled study to compare the efficacy and safety of levocetirizine and bepotastine in chronic spontaneous urticaria

Clinical Dermatology Review, 2023
Background: Management of chronic spontaneous urticaria (CSU) is challenging because of its unpredictable course and negative influence on the quality of life. Second-generation antihistaminics are the first-line treatment. Levocetirizine, a time-tested
Gaurav Menghani, Navneet Kaur, Kapil Vyas, Kalpana Gupta, Kriti Maheshwari, Raju Singh   +5 more
doaj   +1 more source

Advances in malaria pharmacology and the online guide to MALARIA PHARMACOLOGY: IUPHAR review 38

British Journal of Pharmacology, Volume 180, Issue 15, Page 1899-1929, August 2023., 2023
Antimalarial drug discovery has until recently been driven by high‐throughput phenotypic cellular screening, allowing millions of compounds to be assayed and delivering clinical drug candidates. In this review, we will focus on target‐based approaches, describing recent advances in our understanding of druggable targets in the malaria parasite ...
Jane F. Armstrong, Brice Campo, Stephen P. H. Alexander, Lauren B. Arendse, Xiu Cheng, Anthony P. Davenport, Elena Faccenda, David A. Fidock, Karla P. Godinez‐Macias, Simon D. Harding, Nobutaka Kato, Marcus C. S. Lee, Madeline R. Luth, Ralph Mazitschek, Nimisha Mittal, Jacquin C. Niles, John Okombo, Sabine Ottilie, Charisse Flerida A. Pasaje, Alexandra S. Probst, Mukul Rawat, Frances Rocamora, Tomoyo Sakata‐Kato, Christopher Southan, Michael Spedding, Mark A. Tye, Tuo Yang, Na Zhao, Jamie A. Davies   +28 more
wiley   +1 more source

Assessment of flare frequency and severity of generalized pustular psoriasis in Japanese patients: A retrospective chart review study

JEADV Clinical Practice, Volume 2, Issue 2, Page 261-272, June 2023., 2023
Abstract Background Generalized pustular psoriasis (GPP) is a rare and often refractory disease, and GPP flares can be life threatening. The rarity of GPP prevents the development and evaluation of effective GPP‐specific treatments and obstructs disease understanding.
Akimichi Morita, Yukari Okubo, Shinichi Imafuku, Yayoi Tada, Keiichi Yamanaka, Kazumitsu Sugiura, Yukie Yamaguchi, Masahito Yasuda, Hitoshi Tsuchihashi, Morihisa Saitoh, Wataru Sakamoto, Ryuhei Okuyama, the study investigators   +12 more
wiley   +1 more source

A prospective comparative study to evaluate the efficacy and safety of olopatadine eye drops and bepotastine eye drops in subjects of vernal kerato conjunctivitis [PDF]

, 2020
Background: Vernal keratoconjunctivitis (VKC) is an allergic eye disease that especially affects young boys. Both olopatadine and bepotestine are dual acting drugs that provide rapid symptomatic relief coupled with the long-term disease-modifying benefit.
Malahat, Amatur R., Kodudula, Sudhakar, Gali, Vijaya L.   +2 more
core   +1 more source

Comparative observational analysis of clinical outcomes in patients of vernal keratoconjunctivitis treated with eye drops olopatadine or bepotastine besilate

Journal of Medical Evidence, 2022
Objective: Observation and comparison of resolution of signs and relief of symptoms in patients of Vernal Keratoconjunctivitis (VKC) treated with 0.1% olopatadine eye drops or 1.5% bepotastine besilate eye drops.
Preeti Yadav, Ajai Agrawal, Puneet Dhamija, Anupam Singh, Sanjeev Kumar Mittal, Ramanuj Samanta   +5 more
doaj   +1 more source

A case of chronic spontaneous urticaria with wheals lasting for more than a week. [PDF]

J Dermatol
Abstract Urticaria is characterized by the development of wheals which usually disappear within a day, and are not present beyond a few days. A 58‐year‐old man began to develop edematous, partially ring‐shaped erythematous lesions accompanied by severe body itching without any particular cause, approximately 2 months before his first visit to our ...
Morioke S, Moriwaki M, Tanaka A, Hide M.
europepmc   +2 more sources

Bepotastine-induced urticaria, cross-reactive with other antihistamines [PDF]

Asia Pacific Allergy, 2016
Second-generation antihistamines are widely prescribed for the control of symptoms of allergic inflammation such as itchy hives, coryza, and itchy eyes. In rare circumstances, these drugs might provoke allergic inflammation. Hypersensitivity to bepotastine besilate, a second-generation antihistamine has never been reported.
Kang, Ju Wan, Lee, Jaechun
openaire   +2 more sources